Physician
Middle Tennessee Internal Medicine Associates, PLLC
Middle Tennessee Internal Medicine Associates, PLLC was paid $389K by Medicaid between Jan 2018 and Apr 2024, across 29 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 64% of everything it billed.
33Billing provider infoMIDDLE TENNESSEE INTERNAL MEDICINE ASSOCIATES, PLLC
NASHVILLE, TN 37211
NASHVILLE, TN 37211
33aNPI1164489720assigned 04/27/2006
33bProvider typeInternal Medicine Physician
28Total paid$389K
24GClaims18,925
24DCodes billed29
24AFirst – last monthJan 2018 – Apr 2024
Compared with peers
Next to other Internal Medicine Physician providers in Tennessee
Rank by total paid#68 of 581
Median peer was paid$15K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,288 | $79K | |
| 2019 | 1,767 | $56K | |
| 2020 | 1,654 | $33K | |
| 2021 | 3,944 | $61K | |
| 2022 | 3,696 | $71K | |
| 2023 | 4,298 | $71K | |
| 2024incomplete | 1,278 | $19K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 64% | 7,545 | 5,062 | $251K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 4,678 | 3,219 | $108K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.5% | 1,879 | 1,121 | $13K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 282 | 188 | $7K |
| 90682 | 1.1% | 142 | 92 | $4K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 58 | 37 | $3K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 23 | 12 | $959.19 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 151 | 102 | $778.71 |
| 90688 | <1% | 29 | 19 | $319.33 | |
| 81002 | <1% | 294 | 187 | $299.01 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 55 | 31 | $234.56 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 219 | 147 | $190.69 |
17 more codes
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 16 | $88.38 |
| 3078F | <1% | 620 | $70.00 | |
| 3074F | <1% | 664 | $70.00 | |
| 1159F | <1% | 884 | $50.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 45 | $25.73 |
| 3008F | <1% | 714 | $16.20 | |
| 1160F | 0% | 71 | $0.00 | |
| 1033F | 0% | 19 | $0.00 | |
| 1036F | 0% | 163 | $0.00 | |
| 3079F | 0% | 22 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 109 | $0.00 |
| 3014F | 0% | 43 | $0.00 | |
| 3017F | 0% | 68 | $0.00 | |
| 3044F | 0% | 75 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 20 | $0.00 |
| 3048F | 0% | 23 | $0.00 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOSBORNE, TRACY (PRESIDENT)